Abstract：
:Pancreatic cancer and chronic pancreatitis are clinical syndromes associated with severe pain that is difficult to manage. Thus, seeking additional pain reduction therapies is warranted. Excessive alcohol consumption over an extended period of time is the primary causal agent in pancreatitis. The efficacy of a replication defective Herpes (HSV-1, DPE) viral vector construct encoding the human preproenkephalin gene (HSV-Enk), used as a molecular therapy for alleviation of pancreatitis pain, is reviewed here. The characteristics of the gene therapy treatment for inflammation and pain-related behavior in two alcoholic pancreatitis animal models is described. Significant analgesia and protection of pancreatic tissue was provided for the duration of the transgene expression (approximately 4-6 weeks). These studies establish a basis for use of HSV-based gene therapy for chronic visceral pain. Targeted enkephalin gene therapy approaches are providing clear promise for pain control. As innovative means of significantly reducing pancreatic inflammation and preserving tissue architecture, they may extend their clinical usefulness for pancreatitis and pancreatic cancer pain patients.
journal_name
Gene Therjournal_title
Gene therapyauthors
Westlund KNdoi
10.1038/gt.2009.27subject
Has Abstractpub_date
2009-04-01 00:00:00pages
483-92issue
4eissn
0969-7128issn
1476-5462pii
gt200927journal_volume
16pub_type
杂志文章,评审相关文献
GENE THERAPY文献大全abstract：:Transplantation of allogeneic pancreatic islets is an effective approach to treat type 1 diabetes. To bypass the need for systemic administration of immunosuppression drugs following transplantation, approaches to genetically modify allogeneic islets to express anti-inflammatory, immunosuppressive, or antiapoptotic pr...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302530
更新日期：2005-09-01 00:00:00
abstract：:We explored the possibility of using a genetic approach to inhibit integrin-mediated endothelial cell adhesion and survival. We constructed recombinant adenoviruses (Ads) expressing chimeric proteins consisting of the cytoplasmic and transmembrane domains of integrin beta1 (CH1), beta3 (CH3) or the beta1 transmembrane...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301236
更新日期：2000-08-01 00:00:00
abstract：:Cancer therapies that target a single protein or pathway may be limited by their specificity, thus missing key players that control cellular proliferation and contributing to the failure of the treatment. We propose that approaches to cancer therapy that hit multiple targets would limit the chances of escape. To this ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/s41434-019-0096-1
更新日期：2020-02-01 00:00:00
abstract：:This study was designed to evaluate the utility of positron emission tomography (PET) to quantify the magnitude and spatial distribution of transgene expression after different methods of adenoviral vector delivery (with surfactant- and saline-based vehicles) within rat lungs. In all, 17 animals (eight in the surfacta...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302117
更新日期：2003-12-01 00:00:00
abstract：:Radioiodide concentrating activity in the thyroid, mediated by human Na+/I- symporter (hNIS), provides a mechanism for effective radioiodide treatment for patients who have invasive, recurrent, and metastatic thyroid cancers after total thyroidectomy. In an attempt to develop hNIS gene transfer for radioiodide therapy...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301170
更新日期：2000-05-01 00:00:00
abstract：:Herpes simplex virus type 1 (HSV-1) is a neurotrophic human pathogen that naturally persists in neurons in a latent state and carries a large number of viral functions which can be replaced by foreign genes to create a vector for gene therapy applications. In this report we describe a two-step method for insertion/del...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300497
更新日期：1997-10-01 00:00:00
abstract：:Lentiviral vectors pseudotyped with the baculovirus envelope protein GP64 transduce primary cultures of human airway epithelia (HAE) at their apical surface. Our goal in this study was to harness a directed evolution approach to develop a novel envelope glycoprotein with increased transduction properties for HAE. Usin...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2017.78
更新日期：2017-10-01 00:00:00
abstract：:This study characterized gene transfer into both normal and injured adult rat dorsal spinal cord using first (E1-/E3-) or second (E1-/E2A125/E3-, temperature-sensitive; ts) generation of replication-defective adenoviral (Ad) vectors. A novel immunosuppressive regimen aimed at blocking CD4/CD45 lymphocytic receptors wa...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300774
更新日期：1998-12-01 00:00:00
abstract：:Self-amplifying RNA (saRNA) is a promising biotherapeutic tool that has been used as a vaccine against both infectious diseases and cancer. saRNA has been shown to induce protein expression for up to 60 days and elicit immune responses with lower dosing than messenger RNA (mRNA). Because saRNA is a large (~9500 nt), n...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/s41434-019-0095-2
更新日期：2019-09-01 00:00:00
abstract：:Somatic transgenesis can be used to confer endogenous production of proteins with therapeutic properties. One such product, recombinant soluble human CD4 (sCD4), has been shown to be an efficient inhibitor of human immunodeficiency virus 1 (HIV-1) in vitro, but its too short half-life in vivo has impaired long-term cl...
journal_title：Gene therapy
pub_type： 杂志文章
doi：
更新日期：1995-05-01 00:00:00
abstract：:Hepatic sequestration of systemically administered adenoviral vectors reduces the number of viral particles available for delivery to other tissues. The biological basis of this phenomenon was investigated using a new in vivo technique which permitted imaging in real time. Recombinant adenovirus serotype 5 knob (Ad5K)...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300659
更新日期：1998-06-01 00:00:00
abstract：:Reactive oxygen species (ROS) have been implicated in the pathogenesis of rheumatoid arthritis (RA), while antioxidant enzymes, such as extracellular superoxide dismutase (EC-SOD) and catalase, block radical-induced events. The present study tested if the ex vivo transfer of EC-SOD and catalase genes alone or in combi...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301916
更新日期：2003-04-01 00:00:00
abstract：:To induce RNA interference (RNAi), either small interfering RNAs (siRNAs) are directly introduced into the cell or short hairpin RNAs (shRNAs) are expressed from a DNA vector. At present, shRNAs are commonly synthesized by RNA polymerase III (Pol III) promoters of the H1 and U6 RNAs. In this study, we designed and cha...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3303055
更新日期：2008-02-01 00:00:00
abstract：:In order to characterize protein targeting signals in polarized postmitotic cortical neurones in vitro, we have developed recombinant and amplicon type vectors derived from herpes simplex virus 1 (HSV1) to transfer genes into these cells. We examined the targeting of both bacterial proteins, which lack specific target...
journal_title：Gene therapy
pub_type： 杂志文章
doi：
更新日期：1994-01-01 00:00:00
abstract：:The canine is the most important large animal model for testing novel hemophilia A (HA) treatment. It is often necessary to use canine factor VIII (cFIII) gene or protein for the evaluation of HA treatment in the canine model. However, different biological properties between cFVIII and human FVIII (hFVIII) indicated t...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2016.34
更新日期：2016-07-01 00:00:00
abstract：:For patients with metastatic prostate cancer, the 5-year survival rate of 31% points to a need for novel therapies and improvement of existing modalities. We propose that p53 gene therapy and chemotherapy, when combined, will provide superior tumor cell killing for the treatment of prostate carcinoma. To this end, we ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/s41434-019-0071-x
更新日期：2020-02-01 00:00:00
abstract：:Varying degrees of metabolic abnormalities mediated by chronic inflammation are implicated in the chronic glomerular injuries associated with obesity. Interleukin (IL)-10, a pleiotropic cytokine, exerts anti-inflammatory effects in numerous biological settings. In the present study, we explored the biological benefits...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2011.183
更新日期：2012-05-01 00:00:00
abstract：:Hydrodynamic gene delivery to the liver is an attractive approach for clinical liver gene therapy, but critical aspects of technique remain uncertain. There has not been to date any report of high levels of hydrodynamic gene delivery to the liver, except in rodents. Regional hydrodynamic delivery to individual lobes/s...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2009.167
更新日期：2010-04-01 00:00:00
abstract：:Studies reviewed show that lentiviral gene therapy directed either at inhibiting the synthesis of brain acetaldehyde generated from ethanol or at degrading brain acetaldehyde fully prevent ethanol intake by rats bred for their high alcohol preference. However, after animals have chronically consumed alcohol, the above...
journal_title：Gene therapy
pub_type： 杂志文章,评审
doi：10.1038/s41434-019-0064-9
更新日期：2019-11-01 00:00:00
abstract：:Development of efficient short-term gene transfer technologies for embryonic stem (ES) cells is urgently needed for various existing and new ES cell-based research strategies. In this study, we present a highly efficient, nonviral non-DNA technology for genetic loading of mouse ES cells based on electroporation of def...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302342
更新日期：2004-11-01 00:00:00
abstract：:Efficient gene delivery is a critical obstacle for gene therapy that must be overcome. Until current limits of gene delivery technology are solved, identification of systems with bystander effects is highly desirable. As an anticancer agent, radioactive iodine (131)I has minimal toxicity. The physical characteristics ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302758
更新日期：2006-07-01 00:00:00
abstract：:Although systemic administration of neutralizing anti-TNF antibodies has been used successfully in treating rheumatoid arthritis, there is a potential for side effects. We transduced a collagen reactive T-cell hybridoma with tissue-specific homing properties to assess therapeutic effects of local delivery to inflamed ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301980
更新日期：2003-08-01 00:00:00
abstract：:Gene therapy of cystic fibrosis (CF) lung disease needs highly efficient delivery and long-lasting complementation of the CFTR (cystic fibrosis transmembrane conductance regulator) gene into the respiratory epithelium. The development of lentiviral vectors has been a recent advance in the field of gene transfer and th...
journal_title：Gene therapy
pub_type： 杂志文章,评审
doi：10.1038/sj.gt.3302372
更新日期：2004-10-01 00:00:00
abstract：:Episomally maintained self-replicating systems present attractive alternative vehicles for gene therapy applications. Recent insights into the ability of chromosomal scaffold/matrix attachment regions (S/MARs) to mediate episomal maintenance of genetic elements allowed the development of a small circular episomal vect...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302593
更新日期：2006-01-01 00:00:00
abstract：:In 2012, we reported that 5 out of 11 subjects in a clinical trial (NCT00372320) administering AdhAQP1 to radiation-damaged parotid glands showed increased saliva flow rates and decreased symptoms over the initial 42 days. AdhAQP1 is a first-generation, E1-deleted, replication-defective, serotype 5 adenoviral vector e...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2015.55
更新日期：2015-09-01 00:00:00
abstract：:A stable packaging cell line (Vero/BC-F) constitutively expressing fusion (F) protein of the human parainfluenza virus type 2 (hPIV2) was established for production of the F-defective and single round-infectious hPIV2 vector in a strategy for recombinant vaccine development. The F gene expression has not evoked cytost...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2014.55
更新日期：2014-08-01 00:00:00
abstract：:We recently showed that the human telomerase reverse transcriptase (hTERT) promoter induces tumor-specific Bax gene expression and selectively kills various human cancer cells both in vitro and in xenograft tumors. However, it remains unclear whether the hTERT promoter can be used to induce transgene expression in syn...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301619
更新日期：2002-01-01 00:00:00
abstract：:RNA interference (RNAi) was reported to block hepatitis B virus (HBV) gene expression and replication in vitro and in vivo. However, it remains a technical challenge for RNAi-based therapy to achieve long-term and complete inhibition effects in chronic HBV infection, which presumably requires more extensive and unifor...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302846
更新日期：2007-01-01 00:00:00
abstract：:Mobilized blood CD34+ cells from cancer patients were ex vivo infected by a recombinant adenovirus vector carrying an alkaline phosphatase gene, whose expression is evaluable by flow cytometry. A mean of 40% CD34+ cells were infected by the vector, with high levels of expression of the transgene. Among attempts to imp...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300620
更新日期：1998-04-01 00:00:00
abstract：:A novel synthetic polypeptide designed as a DNA binding-molecule for liver-specific, receptor-mediated, gene transfer was used to selectively introduce reporter genes into liver cells in the form of plasmid DNA-ligand complexes. The polypeptide was a D-lysine/D-serine copolymer (Lys/Ser = 33/36 or 53/60) modified with...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300868
更新日期：1999-04-01 00:00:00
